TTOO: T2 Biosystems Inc. Price to Sales

Symbol and logo of brand T2 Biosystems Inc. (TTOO)

T2 Biosystems, Inc. (TTOO) develops rapid systems for detecting bloodborne pathogens. Fluctuations in the P/S multiple illustrate the revenue inertia from test panel sales, where the 0.50 mark characterizes this parameter. T2 Biosystems, Inc. (TTOO) relies on external electronics partners for flexible cartridge production. Sales of T2Dx instruments in intensive care units and large medical centers generate the primary revenue.

TTOO (T2 Biosystems) P/S Multiple history from 07/04/2022 to 02/22/2025

Analytical breakdowns for T2 Biosystems, Inc (TTOO)

- market price and analyst price targets:
Stock Quotes t2biosystems.com|TTOO - Analyst Consensus Forecast
- market capitalization information:
Market Value T2 Biosystems, Inc|TTOO - Enterprise Value
- shareholders' equity book value data:
Equity per Share T2 Biosystems|TTOO - Book Capitalization|Market Capitalization to Book Value t2biosystems.com|TTOO - Company Total Assets
- debt obligations and liquidity statistics:
Total Debt to Equity Ratio T2 Biosystems, Inc.|TTOO - Long-Term Debt to Capital|Short-Term Debt to Capital T2 Biosystems Inc|TTOO - Company Debts|Debt to Book Capitalization Ratio T2 Biosystems, Inc|TTOO - Company Long-Term Liabilities|Company Short-Term Loans and Borrowings T2 Biosystems|Immediate Liquidity t2biosystems.com
- net income and valuation multiples indicators:
TTOO - Company Net Income|Projected Net Profit T2 Biosystems, Inc.|TTOO - Price to Earnings Ratio|Forward P/E Multiple T2 Biosystems Inc.|TTOO - PEG Multiple|Total Company Value to Operating Income Before Depreciation Ratio T2 Biosystems, Inc|TTOO - Profit before payment of interest, taxes and amortization|Earnings per one share for the last 12 months T2 Biosystems|TTOO - Earnings per share for the last twelve months|Year-over-year net earnings per share growth for the last 12 months t2biosystems.com|TTOO - Earnings growth in current year|Expected net earnings per share growth next year T2 Biosystems, Inc.
- issuer revenue and sales details:
TTOO - Company Revenue|Company Revenue Forecast t2biosystems.com|TTOO - Market Cap to Revenue|Price to Expected Revenue Ratio T2 Biosystems, Inc
Fundamental company analysis:t2biosystems.com TTOO
Original product of T2 Biosystems, Inc

T2 Biosystems, Inc. (TTOO) possesses limited pricing power in the rapid sepsis diagnostics segment due to clinical budget constraints, making revenue the key basis for valuation. By analyzing price-to-sales dynamics, investors compare market capitalization with sales volume, which allows them to determine the degree of business overvaluation relative to generated cash flow and assess the fundamental stability of the asset.

Who T2 Biosystems, Inc. competes with

Market Cap to Revenue abbott.com ABT|P/S Multiple TMO (Thermo Fisher)|GE HealthCare Technologies Inc. (GEHC) - Price to Sales|Mettler-Toledo International Inc. - P/S Multiple|WAT (Waters Technologies) - Market Cap to Revenue Ratio|TECH: P/S Multiple|BRKR - Price-to-Revenue Coefficient|AZTA (Azenta) - P/S Multiple|Market Cap to Revenue Varex Imaging Corp (VREX)|P/S Multiple SMLR|P/S Multiple Butterfly Corp (BFLY)|Price-to-Revenue Ratio Mesa Laboratories, Inc. MLAB|quantum-si.com - Price-to-Revenue Ratio|NNOX: Market Cap to Revenue|Market Capitalization-to-Revenue Ratio QTRX (Quanterix Corp.)|MASS: P/S Multiple|Price to Sales CapsoVision (CV)|Price-to-Revenue Ratio MaxCyte, Inc.|RPID - Price-to-Revenue Multiple|Market Cap to Revenue SEER (Seer)|P/S Multiple Hyperfine Inc (HYPR)|P/S Multiple FONR (FONAR Corp)|Price-to-Revenue Coefficient Daxor Corp (DXR)|MDAI - Price-to-Revenue Ratio|Price-to-Sales Ratio VIVS|Aclarion, Inc. (ACON) - Price-to-Revenue Ratio|Market Cap to Revenue Akoya Biosciences, Inc.|THMO (ThermoGenesis Holdings Inc.) - P/S Multiple|Price to Sales Talis Biomedical Corp TLIS